Literature DB >> 18680223

Clinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel disease.

Luciana Rigoli1, Claudio Romano, Rosario Alberto Caruso, Maria A Lo Presti, Chiara Di Bella, Vincenzo Procopio, Giuseppina Lo Giudice, Maria Amorini, Giuseppe Costantino, Maria D Sergi, Caterina Cuppari, Giovanna Elisa Calabro, Romina Gallizzi, Carmelo Damiano Salpietro, Walter Fries.   

Abstract

AIM: To evaluate the role of genetic factors in the pathogenesis of Crohn's disease (CD) and ulcerative colitis (UC), we investigated the single nucleotide polymorphisms (SNPs) of NOD2/CARD15 (R702W, G908R and L1007finsC), and Toll-like receptor 4 (TLR4) genes (D299G and T399I) in a selected inflammatory bowel disease (IBD) population coming from Southern Italy.
METHODS: Allele and genotype frequencies of NOD2/CARD15 (R702W, G908R and L1007finsC) and TLR4 (D299G and T399I) SNPs were examined in 133 CD patients, in 45 UC patients, and in 103 healthy controls. A genotype-phenotype correlation was performed.
RESULTS: NOD2/CARD15 R702W mutation was significantly more frequent in CD (9.8%) than in controls (2.4%, P = 0.001) and in UC (2.3%, P = 0.03). No significant difference was found between UC patients and control group (P > 0.05). In CD and UC patients, no significant association with G908R variant was found. L1007finsC SNP showed an association with CD (9.8%) compared with controls (2.9%, P = 0.002) and UC patients (2.3%, P = 0.01). Moreover, in CD patients, G908R and L1007finsC mutations were significantly associated with different phenotypes compared to CD wild-type patients. No association of IBD with the TLR4 SNPs was found in either cohort (allele frequencies: D299G-controls 3.9%, CD 3.7%, UC 3.4%, P > 0.05; T399I-controls 2.9%, CD 3.0%, UC 3.4%, P > 0.05).
CONCLUSION: These findings confirm that, in our IBD patients selected from Southern Italy, the NOD2/CARD15, but not TLR4 SNPs, are associated with increased risk of CD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18680223      PMCID: PMC2731270          DOI: 10.3748/wjg.14.4454

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  47 in total

Review 1.  The genetics of inflammatory bowel disease.

Authors:  Denise K Bonen; Judy H Cho
Journal:  Gastroenterology       Date:  2003-02       Impact factor: 22.682

2.  A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998.

Authors:  C Gasche; J Scholmerich; J Brynskov; G D'Haens; S B Hanauer; E J Irvine; D P Jewell; D Rachmilewitz; D B Sachar; W J Sandborn; L R Sutherland
Journal:  Inflamm Bowel Dis       Date:  2000-02       Impact factor: 5.325

3.  Novel NOD2 haplotype strengthens the association between TLR4 Asp299gly and Crohn's disease in an Australian population.

Authors:  Georgia E Hume; Elizabeth V Fowler; James Doecke; Lisa A Simms; Ning Huang; Orazio Palmieri; Lyn R Griffiths; Timothy H J Florin; Vito Annese; Graham L Radford-Smith
Journal:  Inflamm Bowel Dis       Date:  2008-05       Impact factor: 5.325

4.  The molecular classification of the clinical manifestations of Crohn's disease.

Authors:  Tariq Ahmad; Alessandro Armuzzi; Mike Bunce; Kim Mulcahy-Hawes; Sara E Marshall; Timothy R Orchard; Jonathan Crawshaw; Oliver Large; Arjuna de Silva; Julia T Cook; Martin Barnardo; Sue Cullen; Ken I Welsh; Derek P Jewell
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

5.  Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypes.

Authors:  Steven R Brant; Michael F Picco; Jean-Paul Achkar; Theodore M Bayless; Sunanda V Kane; Aaron Brzezinski; Franklin J Nouvet; Denise Bonen; Amir Karban; Themistocles Dassopoulos; Reda Karaliukas; Terri H Beaty; Stephen B Hanauer; Richard H Duerr; Judy H Cho
Journal:  Inflamm Bowel Dis       Date:  2003-09       Impact factor: 5.325

6.  Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease.

Authors:  Keiko Yamazaki; Masakazu Takazoe; Torao Tanaka; Toshiki Kazumori; Yusuke Nakamura
Journal:  J Hum Genet       Date:  2002       Impact factor: 3.172

7.  Lack of common NOD2 variants in Japanese patients with Crohn's disease.

Authors:  Nagamu Inoue; Kazuo Tamura; Yoshitaka Kinouchi; Yoshihiro Fukuda; Seiichi Takahashi; Yasunori Ogura; Naohiro Inohara; Gabriel Núñez; Yusuke Kishi; Yuji Koike; Tooru Shimosegawa; Takashi Shimoyama; Toshifumi Hibi
Journal:  Gastroenterology       Date:  2002-07       Impact factor: 22.682

8.  CARD15/NOD2 mutational analysis in Japanese patients with Crohn's disease.

Authors:  M Sugimura; Y Kinouchi; S Takahashi; H Aihara; S Takagi; K Negoro; N Obana; Y Kojima; K Matsumoto; T Kikuchi; M Hiroki; S Oomori; T Shimosegawa
Journal:  Clin Genet       Date:  2003-02       Impact factor: 4.438

9.  Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease.

Authors:  Maria T Abreu; Kent D Taylor; Ying-Chao Lin; Tieu Hang; Joanne Gaiennie; Carol J Landers; Eric A Vasiliauskas; Lori Y Kam; Micha Rojany; Konstantinos A Papadakis; Jerome I Rotter; Stephan R Targan; Huiying Yang
Journal:  Gastroenterology       Date:  2002-09       Impact factor: 22.682

10.  The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease.

Authors:  Andrew P Cuthbert; Sheila A Fisher; Muddassar M Mirza; Kathy King; Jochen Hampe; Peter J P Croucher; Silvia Mascheretti; Jeremy Sanderson; Alastair Forbes; John Mansfield; Stefan Schreiber; Cathryn M Lewis; Christopher G Mathew
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

View more
  19 in total

1.  Role of Salmonella enterica exposure in Chilean Crohn's disease patients.

Authors:  Manuel Alvarez-Lobos; Daniela P Pizarro; Christian E Palavecino; Abner Espinoza; Valentina P Sebastián; Juan C Alvarado; Patricio Ibañez; Carlos Quintana; Orlando Díaz; Alexis M Kalergis; Susan M Bueno
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

2.  NOD2 gene mutations in ulcerative colitis: useless or misunderstood?

Authors:  Paulo Freire; Ricardo Cardoso; Pedro Figueiredo; Maria M Donato; Manuela Ferreira; Sofia Mendes; Ana Margarida Ferreira; Helena Vasconcelos; Francisco Portela; Carlos Sofia
Journal:  Int J Colorectal Dis       Date:  2014-03-22       Impact factor: 2.571

3.  Common NOD2/CARD15 and TLR4 Polymorphisms Are Associated with Crohn's Disease Phenotypes in Southeastern Brazilians.

Authors:  Yolanda F M Tolentino; Paula Peruzzi Elia; Homero Soares Fogaça; Antonio José V Carneiro; Cyrla Zaltman; Rodrigo Moura-Neto; Ronir Raggio Luiz; Maria da Gloria C Carvalho; Heitor S de Souza
Journal:  Dig Dis Sci       Date:  2016-04-23       Impact factor: 3.199

4.  Identification of specific targets for the gut mucosal defense factor intestinal alkaline phosphatase.

Authors:  Kathryn T Chen; Madhu S Malo; Angela K Moss; Skye Zeller; Paul Johnson; Farzad Ebrahimi; Golam Mostafa; Sayeda N Alam; Sundaram Ramasamy; H Shaw Warren; Elizabeth L Hohmann; Richard A Hodin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-05-20       Impact factor: 4.052

Review 5.  Genetic update on inflammatory factors in ulcerative colitis: Review of the current literature.

Authors:  Patricia Sarlos; Erzsebet Kovesdi; Lili Magyari; Zsolt Banfai; Andras Szabo; Andras Javorhazy; Bela Melegh
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

6.  Inflammatory bowel disease in pediatric and adolescent patients: a biomolecular and histopathological review.

Authors:  Luciana Rigoli; Rosario Alberto Caruso
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

7.  NOD2/CARD15 gene mutations in North Algerian patients with inflammatory bowel disease.

Authors:  Aziza Boukercha; Hamida Mesbah-Amroun; Amira Bouzidi; Houria Saoula; Mhamed Nakkemouche; Maryline Roy; Jean-Pierre Hugot; Chafia Touil-Boukoffa
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

8.  Interaction of Crohn's disease susceptibility genes in an Australian paediatric cohort.

Authors:  Josef Wagner; Winnie H Sim; Justine A Ellis; Eng K Ong; Anthony G Catto-Smith; Donald J S Cameron; Ruth F Bishop; Carl D Kirkwood
Journal:  PLoS One       Date:  2010-11-08       Impact factor: 3.240

Review 9.  Intestinal barrier in inflammatory bowel disease.

Authors:  Lena Antoni; Sabine Nuding; Jan Wehkamp; Eduard F Stange
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

10.  Readressing the role of Toll-like receptor-4 alleles in inflammatory bowel disease: colitis, smoking, and seroreactivity.

Authors:  Anastassios C Manolakis; Andreas N Kapsoritakis; Anastasia Kapsoritaki; Elisavet K Tiaka; Konstantinos A Oikonomou; Vassilis Lotis; Dimitra Vamvakopoulou; Ioanna Davidi; Nikolaos Vamvakopoulos; Spyros P Potamianos
Journal:  Dig Dis Sci       Date:  2012-08-24       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.